Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects

Effects of tegoprazan, a novel potassium-competitive acid blocker, on rat models of gastric acid-related disease

(2019) Dongkyu Kim et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis

(2019) Kwang Jae Lee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility

(2017) Nobuyuki Takahashi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects

(2015) H. Jenkins et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects

(2015) Yuuichi Sakurai et al.   Clinical and Translational Gastroenterology

Proton Pump Inhibitors

(2009) Kwong Ming Fock et al.   CLINICAL PHARMACOKINETICS

Insights into the future of gastric acid suppression

(2009) Kenneth R. DeVault et al.   Nature Reviews Gastroenterology & Hepatology

Long-lasting inhibitors of the gastric H,K-ATPase

(2009) Jai Moo Shin et al.   Expert Review of Clinical Pharmacology

Acid peptic diseases: pharmacological approach to treatment

(2009) Alex Mejia et al.   Expert Review of Clinical Pharmacology

Early Stellate Cell Activation and Veno-occlusive-disease (VOD)–like Hepatotoxicity in Dogs Treated with AR-H047108, an Imidazopyridine Proton Pump Inhibitor

(2008) Anna-Lena Berg et al.   TOXICOLOGIC PATHOLOGY